At #ASCO25, Professor Dickon Hayne presented results from the ANZUP 1301 trial showing that adding mitomycin C to BCG may offer a well-tolerated, effective option for high-risk NMIBC. The combination reduced BCG use by 40% – a significant finding amid global shortages – with encouraging efficacy and safety signals.
In this episode, we explore the future of continuing medical education (CME) with the team behind touchIME. Hannah Fisher and Matthew Goodwin share insights into global and US trends, the importance of patient inclusivity and how educational outcomes are evolving to better measure the direct impact of learning on clinical practice and patient care.
We are delighted to present the latest edition of touchREVIEWS in Oncology & Haematology. This issue underscores the evolving landscape of cancer therapeutics, showcasing advances across a wide range of malignancies, from haematologic diseases to solid tumours, through novel mechanisms, ...
The European Oncology Nursing Society (EONS) recognized early the unique challenges that new generations of cancer nurses experience on a personal and professional level, as a result of rapid political and economic changes globally. Therefore, in 2017, in response to the needs and motivations of Young Cancer Nurses (YCN), EONS supported the development of a network for “cancer nurses and general nurses who work in cancer settings and / or with people affected by cancer in the WHO Europe region, who are under the age of 35”.
This May, the World Bladder Cancer Patient Coalition (WBCPC) is launching Bladder Cancer Awareness Month 2025 under the theme “Feeling Unsure? Get Checked”. The campaign highlights the importance of recognising blood in urine as a symptom of bladder cancer and acting quickly to seek medical advice.
Dr Soo Park reflects on the profound impact of mentorship, emphasizing patience and the importance of finding one’s voice. She finds fulfillment in combining science and compassion to support her patients and draws ongoing inspiration from their milestones, viewing her work in oncology as both a privilege and a source of purpose.
BUDAPEST – With a history of medical innovation stretching from Ignaz Semmelweis's groundbreaking antiseptic methods to Endre Mester's pioneering work in laser therapy, Budapest has long played a role in advancing medical science. This May, the tradition continues as the paediatric ...
Acute myeloid leukaemia (AML) is a heterogeneous haematologic cancer associated with clonal expansion of myeloid blasts in the bloodstream, bone marrow and other tissues. AML is associated with blasts expressing various complex molecular and cytogenetic alterations, which play an important ...
"Your professional journey can take many forms, and you have the power to shape it" Dr Ana Tecic Vuger (University Hospital Centre Zagreb, Croatia), a rising voice in breast oncology, shares her reflections on mentorship, professional fulfillment and charting ...
Dr. Pooja Ghatalia, an Associate Professor at Fox Chase Cancer Center, specializes in genitourinary oncology, focusing on kidney and bladder cancers. With expertise in immunotherapy and biomarker development, she combines cutting-edge research with compassionate care. Inspired by exceptional mentors, she advocates for persistence, curiosity, and patient-centered oncology, shaping future oncologists.
Dr Elene Mariamidze (Todua Clinic, Tbilisi) has built a career shaped by diverse mentorship and a commitment to patient-centered oncology. She reflects on invaluable lessons from global experts, the future of oncology, and practical advice for aspiring oncologists entering this challenging yet rewarding field.
Earn and track your CME credits on the go, save articles for later, and follow the latest congress coverage.
Register for free to hear about the latest expert-led education, peer-reviewed articles, conference highlights, and innovative CME activities.
Or use a Social Account.
Explore the latest in medical education and stay current in your field. Create a free account to track your learning.